•  Zydus’s doxycycline hyclate delayed-release tablets has received FDA approval for 75 mg- 100 mg and 150 mg to treat or prevent infections to susceptible bacteria
• Zydus has also received FDA approval for Febuxostat Tablets (US RLD – Uloric) 40 mg and 80 mg to treat hyperuricemia (constantly high levels of uric acid) in adults with gout and helps in reduction
  in pain- swelling- redness- heat- soreness- and stiffness in certain joints
• Additionally- Zydus has received 241 approvals with 340 ANDAs already filed

Ref: Zydus Cadila | Image:  etemaaddaily